CONGRESSO GONO 2023: GOING ON TOWARDS NEW HORIZONS

La Fondazione GONO è un'organizzazione no profit che riconosce tra i punti focali della sua mission la conduzione di esperienze di ricerca clinica e traslazionale che possano concorrere a migliorare il trattamento dei pazienti affetti da diverse neoplasie solide. L'attività della Fondazione è oggi principalmente focalizzata sulle neoplasie gastroenteriche e del distretto testa-collo. Il Congresso annuale rappresenta un'occasione di importante confronto e scambio tra gli sperimentatori già coinvolti ma anche di possibile coinvolgimento per chi desiderasse unirsi ad alcuni degli studi promossi. Verrà fatto il punto sullo stato attuale delle conoscenze con attenzione alle patologie sopra menzionate e verranno evidenziati eventuali gap che gli studi del GONO mirano a colmare.

4 maggio 2023

11.00    Welcome

            Chiara Cremolini          

Setting the scene of no-profit clinical research

Chairs: Giacomo Allegrini, Ornella Garrone

11.10 Main challenges for clinical trials’ design

Massimo Di Maio

11.30 Main challenges for translational research

Filippo Pietrantonio

11.50 Main challenges for study coordinators

Laura Delliponti

12.10 Discussion on the treated topics

All

12.20 Evaluating the response to neoadjuvant immunotherapy: a changing paradigm?

• The pathologist point of view Matteo Fassan
• The radiologist point of view Daniele Regge

12.50 Expert opinion: new endpoints and trial design in the evolving landscape of GI oncology

Elena Elez Fernandez

13.20 Lunch

Colorectal cancer

Chair: Sara Lonardi

14.30 The neoadjuvant treatment of early stages: a new window of opportunity?

Lisa Salvatore

14.50 Adjuvant therapy: waiting for the ctDNA revolution

Roberto Moretto

15.10 dMMR/MSI-high metastatic colorectal cancer: present and future

Sara Lonardi

15.30 ICIs in MSS metastatic colorectal cancer: how to advance the field?

Carlotta Antoniotti

15.50 Later lines of therapy in selected subgroups and in “all comers”

Alessandro Pastorino

16.10 Discussion on the treated topics

All

16.30 Coffee break

17.00 Expert opinion: Coming soon (or not so soon) in CRC: I bet on…

Jenny Seligmann

17.30    End of scientific works

5 maggio 2023

H&N cancer

Chair: Marco C. Merlano

9.00 Challenges and opportunities in integrating immunotherapy in the curative treatment approach     Lisa Licitra

9.20 Designing new trials in recurrent/metastatic setting: what have we learnt from the past?

Paolo Bossi

9.40 Open questions and potential answers by GONO

Consiglia Paduano

10.00 Discussion on the treated topics

All

10.10 Expert opinion: Molecular signatures in HN cancer and their impact on treatment and prognosis

 Ingeborg Tinhofer-Keilholz

Upper GI cancer

Chair: Lorenzo Fornaro

10.40 New treatment strategies in early stages gastroesophageal cancers: beyond chemotherapy Alessandra Raimondi

11.00 New therapeutic targets in advanced gastric cancer

Lorenzo Fornaro

11.20 Discussion on the treated topics

All

11.30 Coffee break

12.00 Selection for immunotherapy in gastroesophageal cancers: from histology to biomarkers

• The pathologist point of view Federica Grillo
• The oncologist point of view Alberto Giovanni Leone

12.30 Treatment strategies in cholangiocarcinoma: time for neoadjuvant and new adjuvant approaches?

Monica Niger 

12.45 New treatment landscape in advanced BTC

Mario Domenico Rizzato

13.00 Expert opinion: how to finally move on in pancreatic cancer

Benedikt Westphalen

13.20 Closing lecture: what’s going on in CRC research in Europe? The effort to build a wide European collaboration

Dominik Modest

13.50 Take home messages and conclusions

Chiara Cremolini

14.00 End of the congress

Nessuna